Cholinergic axon terminals in the ventral tegmental area target a subpopulation of neurons expressing low levels of the dopamine transporter

Journal of Comparative Neurology

Volumn 410, Issue 2, 1999, Pages 197-210

  Garzón, Miguel ^a,b   Vaughan, Roxanne A ^c   Uhl, George R ^d   Kuhar, Michael J ^e   Pickel, Virginia M ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b AUTONOMOUS UNIVERSITY OF MADRID   (Spain)

^c UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e EMORY UNIVERSITY   (United States)

Author keywords

Glutamate; Mesocorticolimbic; Nicotine; Reward; Vesicular acetylcholine transporter

Indexed keywords

ACETYLCHOLINE; CARRIER PROTEIN; DOPAMINE TRANSPORTER; GOLD; PEROXIDASE;

ANIMAL TISSUE; ARTICLE; CELL SUBPOPULATION; CHOLINERGIC NERVE; CONTROLLED STUDY; DENDRITE; DOPAMINERGIC NERVE CELL; FRONTAL CORTEX; LIMBIC CORTEX; MALE; NERVE CELL MEMBRANE; NERVE PROJECTION; NONHUMAN; PERIKARYON; PRIORITY JOURNAL; RAT; SYNAPSE VESICLE; VENTRAL TEGMENTUM;

ACETYLCHOLINE; ANIMALS; CARRIER PROTEINS; COGNITION; CULTURE TECHNIQUES; DENDRITES; DOPAMINE; LIMBIC SYSTEM; MALE; MICROSCOPY, ELECTRON; NERVE ENDINGS; NEURONS, AFFERENT; PRESYNAPTIC TERMINALS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC MEMBRANES; SYNAPTIC VESICLES; VENTRAL TEGMENTAL AREA;

EID: 0033606834     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9861(19990726)410:2<197::AID-CNE3>3.0.CO;2-D     Document Type: Article

References (99)

1. Arvidsson U, Riedl M, Elde R, Meister B. 1997. Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J Comp Neurol 378:454-467.
2. Bayer VE, Pickel VM. 1990. Ultrastructural localization of tyrosine hydroxylase in the rat ventral tegmental area: relationship between immunolabeling density and neuronal associations. J Neurosci 10:2996-3013.
3. Bayer VE, Pickel VM. 1991. GABA-labeled terminals form proportionally more synapses with dopaminergic neurons containing low densities of tyrosine hydroxylase-immunoreactivity in rat ventral tegmental area. Brain Res 559:44-55.
4. Beninato M, Spencer RF. 1998. The cholinergic innervation of the rat substantia nigra: a light and electron microscopic immunohistochemical study. Exp Brain Res 72;178-184.
5. Björklund A, Lindvall O. 1994. Dopamine-containing systems in the CNS. In: Björklund A, Hökfelt T, editors. Handbook of chemical neuroanatomy. vol 2. Classical transmitters in the CNS, Part 1. Amsterdam: Elsevier Science Publishers. p 55-121.
6. Blaha CD, Allen LF, Das S, Inglis WL, Latimer MP, Vincent SR, Winn P. 1996. Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats. J Neurosci 16:714-722.
7. Blanchard V, Raisman-Vozari R, Vyas S, Michel PP, Javoy-Agid, Uhl G, Agid Y. 1994. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon. Mol Brain Res 22:29-38.
8. Bolam JP, Francis CM, Henderson Z. 1991. Cholinergic input to dopaminergic neurons in the substantia nigra: a double immunocytochemical study. Neuroscience 41:483-494.
9. Calabresi P, Lacey MG, North RA. 1989. Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording. Br J Pharmacol 98:135-140.
10. Cerruti C, Walther DM, Kuhar MJ, Uhl GR. 1993. Dopamine transporter mRNA expression is intense in rat midbrain neurons and modest outside midbrain. Mol Brain Res 18:181-186.
11. Chan J, Aoki C, Pickel VM. 1990. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. J Neurosci Methods 33:113-127.
12. Charléty PJ, Grenhoff J, Chergui K, de la Chapelle B, Buda M, Svensson TH, Chouvet G. 1991. Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynurenate. Acta Physiol Scand 142:105-112.
13. Chergui K, Charléty PJ, Akaoka H, Saunier CF, Brunet JL, Buda M, Svensson TH, Chouvet G. 1993. Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur J Neurosci 5:137-144.
14. Christie MJ, Bridge S, James LB, Beart PM. 1985. Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area. Brain Res 333:169-172.
15. Ciliax BJ, Heilman C, Demchyshyn LL, Pristupa ZB, Ince E, Hersch SM, Niznik HB, Levey AI. 1995. The dopamine transporter: immunocytochemical characterization and localization in brain. J Neurosci 15:1714-1723.
16. Clarke PBS. 1990. Mesolimbic dopamine activation - the key to nicotine reinforcement? In: The biology of nicotine dependence (Ciba Foundation Symposium 152). New York: Wiley. p 153-168.
17. Clarke PBS, Pert A. 1985. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348:355-358.
18. Corrigall WA, Coen KM. 1989. Nicotine maintains robust self-administration in rats on a limited-access schedule. Psycopharmacology 99:473-478.
19. Corrigall WA, Coen KM, Adamson KL. 1994. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res 653:278-284.
20. Cortés R, Probst A, Tobler H-J, Palacios JM. 1986. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies. Brain Res 362:239-253.
21. Cox CL, Metherate R, Ashe JH. 1994. Modulation of cellular excitability in neocortex: muscarinic receptor and second messenger-mediated actions of acetylcholine. Synapse 16:123-136.
22. Deutsch AY, Holliday J, Roth R, Chun LLY, Hawrot E. 1987. Immunohistochemical localization of a neuronal nicotinic acetylcholine receptor in mammalian brain. Proc Natl Acad Sci USA 84:8697-8701.
23. Enrico P, Bouma M, De Vries JB, Westerink BHC. 1998. The role of afferents to the ventral tegmental area in the handling stress-induced increase in the release of dopamine in the medial prefrontal cortex: a dual-probe microdialysis in the rat brain. Brain Res 779:205-213.
24. Erickson JD, Varoqui H, Schäfer MK-H, Modi W, Diebler M-F, Weihe E, Rand J, Eiden LE, Bonner TI, Usdin TB. 1994. Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus. J Biol Chem 269:21929-21932.
25. Freed C, Revay R, Vaughan RA, Kriek E, Grant S, Uhl GR, Kuhar MJ. 1995. Dopamine transporter immunoreactivity in rat brain. J Comp Neurol 359:340-349.
26. Gariano RF, Groves PM. 1988. Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices. Brain Res 462:194-198.
27. Gilmor ML, Nash NR, Roghani A, Edwards RH, Yi H, Hersch SM, Levey AI. 1996. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles. J Neurosci 16:2179-2190.
28. Giros B, El Mestikawy S, Bertrand L, Caron G. 1991. Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295:149-154.
29. Goldner FM, Dineley KT, Patrick JW. 1997. Immunohistochemical localization of the nicotinic acetylcholine receptor subunit alpha6 to dopaminergic neurons in the substantia nigra and ventral tegmental area. Neuroreport 8:2739-2742.
30. Góngora-Alfaro JL, Hernández-López S, Martínez-Fong D, Brassart JL, Aceves J. 1991. Activation of nigral M1 and M2 muscarinic receptors produces opposing effects on striatal 3,4-dihydroxyphenylaceticacid measured by in vivo voltametry. Brain Res 554:329-332.
31. Gould E, Butcher LL. 1986. Cholinergic neurons in the rat substantia nigra. Neurosci Lett 63:315-319.
32. Gould E, Woolf NJ, Butcher LL. 1989. Cholinergic projections to the substantia nigra from the pedunculopontine and laterodorsal tegmental nuclei. Neuroscience 28:611-623.
33. Grace AA, Bunney BS. 1984. The control of firing pattern in nigral dopamine neurons: burst firing. J Neurosci 4:2877-2890.
34. Gray EG. 1959. Axosomatic and axo-dendritic synapses of the cerebral cortex: an electron microscopic study. J Anat 93:420-433.
35. Grenhoff J, Aston-Jones G, Svensson TH. 1986. Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128:351-358.
36. Gronier B, Rasmussen K. 1998. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat. Br J Pharmacol 124:455-464.
37. Haber SN, Ryoo H, Cox C, Lu W. 1995. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter - comparison with the mRNA for the D-2 receptor, tyrosine hydroxylase and calbindin immunoreactivity. J Comp Neurol 362:400-410.
38. Hallanger AE, Wainer BH. 1988. Ascending projections from the pedunculopontine tegmental nucleus and the adjacent mesopontine tegmentum in the rat. J Comp Neurol 274:483-515.
39. Henderson Z, Sherriff FE. 1991. Distribution of choline acetyltransferase immunoreactive axons and terminals in the rat and ferret brainstem. J Comp Neurol 314:147-163.
40. Hsu SM, Raine L, Fanger H. 1981. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (peroxidase) procedures. J Histochem Cytochem 29:577-599.
41. 2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons. Neuroscience 63:357-362.
42. Imperato A, Mulas A, Di Chiara G. 1996. Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132:337-338.
43. Karreman M, Westerink BHC, Moghaddam B. 1996. Excitatory amino acid receptors in the ventral tegmental area regulate dopamine release in the ventral striatum. J Neurochem 67:601-607.
44. Kilty JE, Lorang D, Amara SG. 1991. Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254:578-579.
45. Kuhar MJ. 1998. Recent biochemical studies of the dopamine transporter - a CNS drug target. Life Sci 62:1573-1575.
46. 1-like receptors. J Pharmacol Exp Ther 253:395-400.
47. Lavoie B, Parent A. 1994. Pedunculopontine nucleus in the squirrel monkey: cholinergic and glutamatergic projections to the substantia nigra. J Comp Neurol 344:232-241.
48. Leranth C, Pickel VM. 1989. Electron microscopic pre-embedding double immnunostaining methods. In: Heimer L, Zaborsky L, editors. Tract tracing methods 2, recent progress. New York: Plenum. p 129-172.
49. Martínez-Murillo R, Villalba R, Montero-Caballero M-I, Rodrigo J. 1989. Cholinergic somata and terminals in the rat substantia nigra: an immunocytochemical study with optical and electron microscopic techniques. J Comp Neurol 281:397-415.
50. Mathe JM, Nomikos GG, Schilstrom B, Svensson TH. 1998. Non-NMDA excitatory amino acid receptors in the ventral tegmental area mediate systemic dizocilpine (MK-801) induced hyperlocomotion and dopamine release in the nucleus accumbens. J Neurosci Res 51:583-592.
51. 3H-GBR 12935. J Neural Transm 87:1-14.
52. Mereu G, Yoon K-WP, Boi V, Gessa GL, Naes L, Westfall TC. 1987. Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol 141:395-399.
53. Mesulam M-M, Mash D, Hersh L, Bothwell M, Geula C. 1992. Cholinergic innervation of the human striatum, globus pallidus, subthalamic nucleus, substantia nigra, and red nucleus. J Comp Neurol 323:252-268.
54. Nirenberg MJ, Chan J, Pohorille A, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM. 1997a. The dopamine transporter: comparative ultrastructure of dopaminergic axons in limbic and motor compartments of the nucleus accumbens. J Neurosci 17:6899-6907.
55. Nirenberg MJ, Chan J, Vaughan RA, Uhl G, Kuhar MJ, Pickel VM. 1997b. Immunogold localization of the dopamine transporter: an ultrastructural study of the rat ventral tegmental area. J Neurosci 17:4037-4044.
56. Nisell M, Nomikos GG, Svensson TH. 1994a. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol Toxicol 75:348-352.
57. Nisell M, Nomikos GG, Svensson TH. 1994b. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotine receptors in the ventral tegmental area. Synapse 16:36-44.
58. Oades RD, Halliday GM. 1987. Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res Rev 12:117-165.
59. Oakman SA, Faris PL, Kerr PE, Cozzari C, Hartman BK. 1995. Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area. J Neurosci 15:5859-5869.
60. Panagis G, Nisell M, Nomikos GG, Chergui K, Svensson TH. 1996. Nicotine injections into the ventral tegmental area increase locomotion and fos-like immunoreactivity in the nucleus accumbens of the rat. Brain Res 730:133-142.
61. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. San Diego: Academic Press.
62. Peters A, Palay SL, Webster HD. 1991. The fine structure of the nervous system: neurons and their supporting cells. Oxford: Oxford University Press.
63. Pickel VM. 1986. Ultrastructure of central catecholaminergic neurons. In: Panula P, Paivarinta H, Soinila S, editors. Neurohistochemistry: modern methods and applications. New York: Alan R. Liss. p 397-423.
64. Pidoplichko VI, DeBiasi M, Williams JT, Dani JA. 1997. Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390:401-404.
65. Revay R, Vaughan R, Grant S, Kuhar MJ. 1996. Dopamine transporter immunohistochemistry in median eminence, amygdala, and other areas. Synapse 22:93-99.
66. Reynolds ES. 1963. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J Cell Biol 17:208.
67. Roghani A, Feldman J, Kohan SA, Shirzadi A, Gundersen CB, Brecha N, Edwards RH. 1994. Molecular cloning of a putative vesicular transporter for acetylcholine. Proc Natl Acad Sci USA 91:10620-10624.
68. Roghani A, Shirzadi A, Kohan SA, Edwards RH, Butcher LL. 1996. Differential distribution of the putative vesicular transporter for acetylcholine in the rat central nervous system. Mol Brain Res 43:65-76.
69. Roghani A, Shirzadi A, Butcher LL, Edwards RH. 1998. Distribution of the vesicular transporter for acetylcholine in the rat central nervous system. Neuroscience 82:1195-1212.
70. Sanghera MK, Trulson ME, German DC. 1984. Electrophysiological properties of mouse dopamine neurons: in vivo and in vitro studies. Neuroscience 12:793-801.
71. Schäfer MK-H, Weihe E, Varoqui H, Eiden LE. 1994. Distribution of the vesicular acetylcholine transporter (VAChT) in the central and peripheral nervous system. J Mol Neurosci 5:1-26.
72. Schäfer MK-H, Eiden LE, Weihe E.1998. Cholinergic neurons and terminal fields revealed by immunohistochemistry for the vesicular acetylcholine transporter. I. Central nervous system. Neuroscience 84:331-359.
73. Schilström B, Nomikos GG, Nisell M, Hertel P, Svensson TH. 1998. N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemid nicotine-induced dopamine release in the nucleus accumbens. Neuroscience 82:781-789.
74. Sesack SR, Pickel VM. 1992. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 320:145-160.
75. Sesack SR, Deutch AY, Roth RH, Bunney BS. 1989. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris-leucoagglutinin. J Comp Neurol 290:213-242.
76. Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI. 1998. Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18:2697-2708.
77. Shimada S, Kitayama S, Lin CL, Patel A, Nanthakumar E, Gregor P, Kuhar M, Uhl G. 1991. Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA (published erratum appears in Science [1992] 255:1195). Science 254:576-578.
78. Shimada S, Kitayama S, Walther D, Uhl G. 1992. Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Mol Brain Res 13:359-362.
79. Smith Y, Charara A, Parent A.1996. Synaptic innervation of midbrain dopaminergic neurons by glutamate-enriched terminals in the squirrel monkey. J Comp Neurol 364:231-253.
80. Smith Y, Koylu EO, Couceyro P, Kuhar MJ. 1997. Ultrastructural localization of CART (cocaine- and amphetamine-regulated transcript) peptides in the nucleus accumbens of monkeys. Synapse 27:90-94.
81. Smith Y, Bevan MD, Shink E, Bolam JP. 1998. Microcircuitry of the direct and indirect pathways of the basal ganglia. Neuroscience 86:353-387.
82. Steffensen SC, Svingos AL, Pickel VM, Henriksen SJ. 1998. Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J Neurosci 18:8003-8015.
83. Suaud-Chagny MF, Chergui K, Chouvet G, Gonon F. 1992. Relationship between dopamine release in the rat nucleus accumbens and the discharge activity of dopaminergic neurons during local in vivo application of amino acids in the ventral tegmental area. Neuroscience 49:63-72.
84. Summers KL, Giacobini E. 1995. Effects of local and repeated systemic administration of (-)nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine and serotonin in rat cortex. Neurochem Res 20:753-759.
85. Swanson LW, Simmons DM, Whiting PJ, Lindstrom J. 1987. Immunohistochemical localization of neuronal nicotinic receptors in the rodent central nervous system. J Neurosci 7:3334-3342.
86. Tandon R, Greden JF. 1989. Cholinergic hyperactivity and negative schizophrenic symptoms. Arch Gen Psychiatry 46:745-753.
87. Tandon R, Shipley JE, Greden JF, Mann NA, Eisner WH, Goodson J. 1991. Muscarinic cholinergic hyperactivity in schizophrenia. Relationship to positive and negative symptoms. Schizophrenia Res 4:23-30.
88. Tuffet S, Grandier-Vazeilles X, Geffard M. 1987. Monoclonal antibodies against glutaraldehyde-conjugated dopamine. J Neurochem 49:487-494.
89. Usdin TB, Eiden LE, Bonner TI, Erickson JD. 1995. Molecular biology of the vesicular Ach transporter. TINS 18:218-224.
90. Van Bockstaele EJ, Pickel VM. 1995. GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain. Brain Res 682:215-221.
91. Vidal C. 1994. Nicotinic potentiation of glutamatergic synapses in the prefrontal cortex: new insight into the analysis of the role of nicotinic receptors in cognitive functions. Drug Dev Res 31:120-126.
92. Vilaro MT, Palacios JM, Mengod G. 1990. Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry. Neurosci Lett 114:154-159.
93. Weihe E, Tao-Cheng J-H, Schäfer MK-H, Erickson JD. 1996. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. Proc Natl Acad Sci USA 93:3547-3552.
94. Westerink BHC, Kwint H-F, De Vries JB. 1996. The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain. J Neurosci 16:2605-2611.
95. Westerink BH, Enrico P, Feimann J, De Vries JB. 1998. The pharmacology of mesocortical dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain. J Pharmacol Exp Ther 285:143-154.
96. Wonnacott S, Soliakov L, Wilkie G, Redfern P, Marshall D. 1996. Presynaptic nicotinic acetylcholine receptors in the brain. Drug Dev Res 38:149-159.
97. Woolf NJ, Harrison JB, Buchwald JS. 1990. Cholinergic neurons of the feline pontomesencephalon II. Ascending anatomical projections. Brain Res 520:55-72.
98. Yeomans JS. 1995. Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology 12:3-16.
99. Yeomans J, Baptista M. 1997. Both nicotinic and muscarinic receptors in ventral tegmental area contribute to brain-stimulation reward. Pharmacol Biochem Behav 57:915-921.